These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16261170)

  • 21. Drugs targeting the ribosome.
    Hermann T
    Curr Opin Struct Biol; 2005 Jun; 15(3):355-66. PubMed ID: 15919197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribosome-targeting antibiotics and mechanisms of bacterial resistance.
    Wilson DN
    Nat Rev Microbiol; 2014 Jan; 12(1):35-48. PubMed ID: 24336183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species-specific antibiotic-ribosome interactions: implications for drug development.
    Wilson DN; Harms JM; Nierhaus KH; Schlünzen F; Fucini P
    Biol Chem; 2005 Dec; 386(12):1239-52. PubMed ID: 16336118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics.
    Svetlov MS; Vázquez-Laslop N; Mankin AS
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13673-13678. PubMed ID: 29229833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribosome Protection Proteins-"New" Players in the Global Arms Race with Antibiotic-Resistant Pathogens.
    Ero R; Yan XF; Gao YG
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.
    Lin J; Zhou D; Steitz TA; Polikanov YS; Gagnon MG
    Annu Rev Biochem; 2018 Jun; 87():451-478. PubMed ID: 29570352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Context-specific action of macrolide antibiotics on the eukaryotic ribosome.
    Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS
    Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of Dirithromycin Bound to the Bacterial Ribosome Suggests New Ways for Rational Improvement of Macrolides.
    Khabibullina NF; Tereshchenkov AG; Komarova ES; Syroegin EA; Shiriaev DI; Paleskava A; Kartsev VG; Bogdanov AA; Konevega AL; Dontsova OA; Sergiev PV; Osterman IA; Polikanov YS
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures.
    Pfister P; Hobbie S; Vicens Q; Böttger EC; Westhof E
    Chembiochem; 2003 Oct; 4(10):1078-88. PubMed ID: 14523926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome.
    Seefeldt AC; Graf M; Pérébaskine N; Nguyen F; Arenz S; Mardirossian M; Scocchi M; Wilson DN; Innis CA
    Nucleic Acids Res; 2016 Mar; 44(5):2429-38. PubMed ID: 26792896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissecting the Nucleoside Antibiotics as Universal Translation Inhibitors.
    Nelli MR; Heitmeier KN; Looper RE
    Acc Chem Res; 2021 Jul; 54(13):2798-2811. PubMed ID: 34152729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Bright Future for Antibiotics?
    Matzov D; Bashan A; Yonath A
    Annu Rev Biochem; 2017 Jun; 86():567-583. PubMed ID: 28654325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
    Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
    Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The macrolide-bacterium interaction and its biological basis.
    Goldman RC; Scaglione F
    Curr Drug Targets Infect Disord; 2004 Sep; 4(3):241-60. PubMed ID: 15379734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling.
    Borovinskaya MA; Pai RD; Zhang W; Schuwirth BS; Holton JM; Hirokawa G; Kaji H; Kaji A; Cate JH
    Nat Struct Mol Biol; 2007 Aug; 14(8):727-32. PubMed ID: 17660832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The structures of four macrolide antibiotics bound to the large ribosomal subunit.
    Hansen JL; Ippolito JA; Ban N; Nissen P; Moore PB; Steitz TA
    Mol Cell; 2002 Jul; 10(1):117-28. PubMed ID: 12150912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.
    Goldman RC; Kadam SK
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1058-66. PubMed ID: 2506804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescently labeled ribosomes as a tool for analyzing antibiotic binding.
    Llano-Sotelo B; Hickerson RP; Lancaster L; Noller HF; Mankin AS
    RNA; 2009 Aug; 15(8):1597-604. PubMed ID: 19553343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving on nature: antibiotics that target the ribosome.
    Sutcliffe JA
    Curr Opin Microbiol; 2005 Oct; 8(5):534-42. PubMed ID: 16111914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structures of antibiotics bound to the E site region of the 50 S ribosomal subunit of Haloarcula marismortui: 13-deoxytedanolide and girodazole.
    Schroeder SJ; Blaha G; Tirado-Rives J; Steitz TA; Moore PB
    J Mol Biol; 2007 Apr; 367(5):1471-9. PubMed ID: 17321546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.